Effects of tetracaine and bupivacaine on chemiluminescence generated by formyl-methionyl-leucyl-phenylalanine-stimulated human leukocytes and cell-free systems

International Immunopharmacology

Volumn 3, Issue 5, 2003, Pages 757-764

  Günaydin, Berrin ^a   Demiryürek, A Tuncay ^a,b  

^a GAZI UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Bupivacaine; Chemiluminescence; Free radicals; Leukocytes; Tetracaine

Indexed keywords

ANESTHETIC AGENT; BUPIVACAINE; ESTER; FERRIC SULFATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; LUCIGENIN; LUMINOL; PEROXYNITRITE; SUPEROXIDE; TETRACAINE;

ARTICLE; CELL FREE SYSTEM; CHEMOLUMINESCENCE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; PRIORITY JOURNAL;

EID: 0037687958     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00077-8     Document Type: Article

References (37)

1. Reilly P.M., Schiller H.J., Bulkley G.B. Pharmacological approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am. J. Surg. 161:1991;488-503.
2. Kang M.Y., Tsuchiya M., Packer L., Manabe M. In vitro study on antioxidant potential of various drugs used in the preoperative period. Acta Anaesthesiol. Scand. 42:1998;4-12.
3. Sasagawa S. Inhibitory effects of local anaesthetics on migration, extracellular release of lysosomal enzyme, and superoxide anion production in human polymorphonuclear leukocytes. Immunopharmacol. Immunotoxicol. 13:1991;607-622.
4. Gunaydin B., Demiryurek A.T. Effects of prilocaine and articaine on human leukocytes and reactive oxygen species in vitro. Acta Anaesthesiol. Scand. 45:2001;741-745.
5. Gunaydin B., Demiryurek A.T. Interaction of lidocaine with reactive oxygen and nitrogen species. Eur. J. Anaesthesiol. 18:2001;816-822.
6. Mikawa K., Akamatsu H., Nishina K., Shiga M., Maekawa N.et al. Inhibitory effect of local anaesthetics on reactive oxygen species production by human neutrophils. Acta Anaesthesiol. Scand. 41:1997;524-528.
7. Aitkenhead A.R., Rowbotham D.J., Smith G. Textbook of Anaesthesia. 2001;Churchill Livingstone, London.
8. McLeod G.A., Burke D. Levobupivacaine. Anaesthesia. 56(4):2001;331-341.
9. Rodenas J., Mitjavila M.T., Carbonell T. Simultaneous generation of nitric oxide and superoxide by inflammatory cells in rats. Free Radic. Biol. Med. 18(5):1995;869-875.
10. Demiryurek A.T., Cakici I., Kanzik I. Peroxynitrite: a putative cytotoxin. Pharmacol. Toxicol. 82(3):1998;113-117.
11. Van Dyke K., Van Scott M.R., Castranova V. Measurement of phagocytosis and cell mediated cytotoxicity by chemiluminescence. Methods Enzymol. 132:1986;498-507.
12. Edwards S.W. Luminol- and lucigenin-dependent chemiluminescence of neutrophils: role of degranulation. J. Clin. Lab. Immunol. 22:1987;35-39.
13. Weber G.F. The measurement of oxygen-derived free radicals and related substances in medicine. J. Clin. Chem. Clin. Biochem. 28:1990;569-603.
14. Yildiz G., Demiryurek A.T. Ferrous iron-induced luminol chemiluminescence: a method for hydroxyl radical study. J. Pharmacol. Toxicol. Methods. 39:1998;179-184.
15. Demiryurek A.T., Cinel I., Kahraman S., Tecder-Unal M., Gogus N.et al. Propofol and intralipid interact with reactive oxygen species: a chemiluminescence study. Br. J. Anaesth. 80:1998;649-654.
16. Yildiz G., Demiryurek A.T., Şahin-Erdemli I., Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br. J. Pharmacol. 124:1998;905-910.
17. Vissers M., Stern A., Kuypers A., Vandenberg J., Winterburn C. Membrane changes associated with lysis of red blood cells by hypochlorous acid. Free Radic. Biol. Med. 16:1994;703-712.
18. Beckman J.S., Chen J., Ischiropoulos H., Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233:1994;229-240.
19. Kahraman S., Demiryurek A.T. Propofol is a peroxynitrite scavenger. Anesth. Analg. 84:1997;1127-1129.
20. Irita K., Fujita I., Takeshige K., Minakami S., Yoshitake J. Cinchocaine and amethocaine inhibit activation and activity of superoxide production in human neutrophils. Br. J. Anaesth. 58:1986;639-645.
21. Azuma Y., Shinohara M., Wang P.L., Suese Y., Yasuda H., Ohura K. Comparison of inhibitory effects of local anesthetics on immune functions of neutrophils. Int. J. Immunopharmacol. 22:2000;789-796.
22. Goldstein I.M., Lind S., Hoffstein S., Weissmann G. Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production. J. Exp. Med. 146:1977;483-494.
23. Mazumdar B., Tomlinson A.A., Faulder G.C. Preliminary study to assay plasma amethocaine concentrations after topical application of a new local anaesthetic cream containing amethocaine. Br. J. Anaesth. 67:1991;432-436.
24. Cederholm I., Briheim G., Rutberg H., Dahlgren C. Effects of five amino-amide local anaesthetic agents on human polymorphonuclear leukocytes measured by chemiluminescence. Acta Anaesthesiol. Scand. 38:1994;704-710.
25. Mikawa K., Akamatsu H., Nishina K., Shiga M., Maekawa N.et al. Inhibitory effect of local anaesthetics on reactive oxygen species production by human neutrophils. Acta Anaesthesiol. Scand. 41(4):1997;524-528.
26. Jorfeldt L., Lofstrom B., Pernow B., Persson B., Wahren J., Widman B. The effect of local anaesthetics on the central circulation and respiration in man and dog. Acta Anaesthesiol. Scand. 12:1968;153-169.
27. Bernards C.M., Carpenter R.L., Rupp S.M., Brown D.L., Morse B.V.et al. Effect of midazolam and diazepam premedication on central nervous system and cardiovascular toxicity of bupivacaine in pigs. Anesthesiology. 70:1989;318-323.
28. Lindgren L., Randell T., Suzuki N., Kytta J., Yli-Hankala A., Rosenberg P.H. The effect of amrinone on recovery from severe bupivacaine intoxication in pigs. Anesthesiology. 77:1992;309-315.
29. Watson R.L., Brown P.W., Reich M.P. Venous and arterial bupivacaine concentrations after intravenous regional anesthesia. Anesth. Analg. 49:1970;300-304.
30. Mather L.E., Long G.J., Thomas J. The intravenous toxicity and clearance of bupivacaine in man. Clin. Pharmacol. Ther. 12:1971;935-943.
31. Martinsson T., Oda T., Fernvik E., Roempke K., Dalsgaard C.J., Svensjo E. Ropivacaine inhibits leukocyte rolling, adhesion and CD11b/CD18 expression. J. Pharmacol. Exp. Ther. 283:1997;59-65.
32. Hattori M., Dohi S., Nozaki M., Niwa M., Shimonaka H. The inhibitory effects of local anesthetics on superoxide generation of neutrophils correlate with their partition coefficients. Anesth. Analg. 84:1997;405-412.
33. Welters I.D., Menzebach A., Langefeld T.W., Menzebach M., Hempelmann G. Inhibitory effects of S-(-) and R-(+) bupivacaine on neutrophil function. Acta Anaesthesiol. Scand. 45:2001;570-575.
34. Celebi H., Bozkirli F., Gunaydin B., Bilgihan A. Effect of high-dose lidocaine treatment on superoxide dismutase and malon dialdehyde levels in seven diabetic patients. Reg. Anesth. Pain Med. 25:2000;279-282.
35. Mikawa K., Maekawa N., Nishina K., Takao Y., Yaku H., Obara H. Effect of lidocaine pretreatment on endotoxin-induced lung injury in rabbits. Anesthesiology. 81:1994;689-699.
36. Martinsson T., Ljung T., Rubio C., Hellstrom P.M. Beneficial effects of ropivacaine in rat experimental colitis. J. Pharmacol. Exp. Ther. 291:1999;642-647.
37. Hollmann M.W., Durieux M.E. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 93:2000;858-875.